Skip to main content

Table 2 Disease Activity Sub-Groups In Patients Followed Over Three Or More Years

From: Real world long-term impact of intensive treatment on disease activity, disability and health-related quality of life in rheumatoid arthritis

 

Always Remission

Some Remission

No Remission

Significance

(n = 68)

(n = 376)

(n = 308)

 

Females (%)

34 (50%)

299 (80%)

246 (80%)

P < 0.001*

Caucasian Ethnicity (%)

58 (85%)

287 (76%)

195 (63%)

P < 0.001*

Black African/Caribbean Ethnicity (%)

1 (2%)

37 (10%)

62 (20%)

P < 0.001*

Initial Mean Age In Years (SD)

54 (16)

55 (15)

56 (14)

NS**

Initial Disease Duration In Years (SD)

5 (5)

10 (9)

12 (11)

P = 0.003**

Initial Mean DAS28 (SD)

1.65 (0.65)

3.48 (1.32)

4.65 (1.19)

P < 0.001**

Overall Mean DAS28 (SD)

1.57 (0.45)

3.06 (0.71)

4.47 (0.82)

P < 0.001**

Any Flares (%)

27 (40%)

266 (71%)

194 (63%)

P < 0.001*

Overall Mean EQ5D-3 L (SD)

0.77 (0.17)

0.58 (0.24)

0.38 (0.28)

P < 0.001**

Initial Mean HAQ (SD)

0.31 (0.50)

1.06 (0.81)

1.58 (0.81)

P < 0.001**

Overall Mean HAQ (SD)

0.31 (0.45)

1.03 (0.70)

1.66 (0.67)

P < 0.001**

HAQ Below 0.50 On One Or More Occasion (%)

58 (85%)

180 (48%)

56 (18%)

P < 0.001*

  1. *Chi-Squared Testing **One Way Analysis Of Variance